Skip to main content
. 2013 Sep 19;145(1):108–112. doi: 10.1378/chest.13-1071

Table 1.

—Baseline Demographic and Clinical Characteristics of Patients With LAM

Characteristic Value
Age, mean ± SEM, y
 At presentation with LAM-related symptoms 36.8 ± 8.6
 At diagnosis of LAM symptoms 40.9 ± 8.4
 At enrollment in the NHLBI LAM protocol 42.7 ± 8.1
 At initiation of sirolimus therapy 47.2 ± 10.0
 At most recent follow-up visit 49.7 ± 9.3
Interval from diagnosis to initiation of sirolimus therapy, mean ± SD, y 6.3 ± 6.7
Race
 White 20 (87)
 African American 1 (4)
 Asian 1 (4)
 Unknown 1 (4)
Clinical features
Tuberous sclerosis complex 4 (17)
Postmenopausal 9 (39)
History of pneumothorax 7 (30)
History of dyspnea 15 (65)
Requirement for oxygen therapy 9 (39)
Chylous pleural effusions 10 (43)
Ascites 6 (26)
Lymphangioleiomyomas 16 (70)
Lymphadenopathy 6 (26)
Renal angiomyolipoma 7 (30)

Data are presented as No. (%) unless otherwise indicated. LAM = lymphangioleiomyomatosis; NHLBI = National Heart, Lung, and Blood Institute.